Thursday, March 21, 2019
7:30 am – 12:00 pm
Free for RWC Main Program Attendees!

Faculty

Meet Our Honorary Event Chairs:

    Pravin U. Dugel, MD
  • Pravin U. Dugel, MD
  • Managing Partner
  • Retinal Consultants of Arizona LTD
  • Retinal Research Institute LLC
  • Phoenix, Arizona
  • Clinical Professor
  • USC Roski Eye Institute
  • Keck School of Medicine
  • University of Southern California
  • Los Angeles, California
    Peter K. Kaiser, MD
  • Peter K. Kaiser, MD
  • Professor of Ophthalmology
  • Cleveland Clinic Lerner
  • College of Medicine
  • Chaney Family Endowed Chair in Ophthalmology Research
  • Cole Eye Institute
  • Cleveland, Ohio
    Baruch D. Kuppermann, MD, PhD
  • Baruch D. Kuppermann, MD, PhD
  • Roger F. Steinert Endowed Professor
  • Chair
  • Department of Ophthalmology
  • Director
  • UCI Health Gavin Herbert Eye Institute
  • Irvine, California

Faculty

  • Eddy Anglade, MD
  • Vice President, Ophthalmology
  • Astellas Pharma Global Development, Inc.
  • Astellas Institute for Regenerative Medicine
  • Marlborough, Massachusetts
  • Robert Avery, MD
  • Founder and CEO
  • California Retina Consultants
  • Santa Barbara, California
  • Remko Bakker
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • Ulm Area, Germany
  • Sophie J. Bakri, MD
  • Professor of Ophthalmology
  • Mayo Clinic
  • Rochester, Minnesota
  • Richard L. Beckman, MD
  • Chief Medical Officer
  • ReNeuron, Inc.
  • Warwick, Arizona
  • Francine Behar-Cohen, MD, PhD
  • Department of Ophthalmology
  • Hôpital Cochin Paris
  • Université Paris Descartes
  • Centre de Recherche des Cordeliers
  • Paris, France
  • Paul Bresge
  • Chief Executive Officer
  • jCyte
  • Newport Beach, California
  • Wiley Chambers, MD
  • Supervisory Medical Officer of Ophthalmology
  • Food and Drug Administration
  • Washington, DC
  • Yan Cheng, MD, PhD
  • Chief Medical Officer
  • Global Clinical Research
  • Chengdu Kanghong Biotechnology Co., Ltd
  • Chengdu, China
  • David R. Chow, MD, FRCSC
  • St. Michael’s Hospital
  • University of Toronto
  • Toronto Retina Institute
  • Toronto, Ontario
  • Dixon Davis, MBA, MHA
  • Principal and Senior Consultant
  • BSM Consulting
  • Salt Lake City, Utah
  • Jay S. Duker, MD
  • Director
  • New England Eye Center
  • Professor and Chairman
  • Department of Ophthalmology
  • Tufts Medical Center
  • Tufts University
  • School of Medicine
  • Boston, Massachusetts
  • D. Scott Edwards, PhD
  • Vice President and General Manager
  • SciFluor Life Sciences, Inc.
  • Cambridge, Massachusetts
  • Jean H. M. Feyen, PhD
  • Adjunct Professor
  • Chief Scientific Officer
  • Oxurion NV
  • Leuven, Belgium
  • Alan J. Franklin, MD, PhD
  • Mobile Infirmary Medical Center
  • RFE Pharma
  • Mobile, Alabama
  • Mehdi Gasmi, PhD
  • President and Chief Scientific Officer
  • Adverum Biotechnologies, Inc.
  • Menlo Park, California
  • Andrea Gibson, PhD
  • Medical Director, Medical Affairs Ophthalmology
  • Regeneron Pharmaceuticals, Inc
  • Tarrytown, New York
  • William Greene, MD
  • Iconic Therapeutics
  • South San Francisco, California
  • Tarek S. Hassan, MD
  • Professor of Ophthalmology
  • Oakland University
  • William Beaumont
  • School of Medicine
  • Partner and Director
  • Vitreoretinal Fellowship Training
  • Associated Retinal Consultants, P.C.
  • Royal Oak, Michigan
  • Theresa G. H. Heah, MD, MBA
  • Vice President
  • Clinical, Medical and Professional Affairs
  • Aerie Pharmaceutical, Inc.
  • Bedminster, New Jersey
  • Stephen Hoffman, MD, PhD
  • Chief Executive Officer
  • Aerpio Pharmaceuticals
  • Cincinnati, Ohio
  • Hampar Karageozian, MSc, MBA
  • Executive Chairman
  • Allegro Ophthalmics
  • San Juan Capistrano, California
  • Amir H. Kashani, MD, PhD
  • Assistant Professor
  • USC Roski Eye Institute
  • Keck School of Medicine
  • Los Angeles, California
  • Eliot Lazar, MD, MS, MBA
  • President
  • eICON Enterprises, Inc.
  • Orchard Park, New York
  • Brian Levy, OD
  • CEO
  • OcuNexus Therapeutics, Inc.
  • San Diego, California
  • Nancy Lurker
  • President and CEO
  • EyePoint Pharmaceuticals
  • Watertown, Massachusetts
  • Reenie McCarthy
  • Chief Executive Officer
  • Stealth BioTherapeutics
  • Hopkinton, Massachusetts
  • Ken Mills
  • President
  • Chief Executive Officer
  • REGENXBIO Inc.
  • Rockville, Maryland
  • Wendy Naimark, PhD
  • Vice President, R&D
  • Interface Biologics
  • Ontario, Canada
  • Ram Palanki, PharmD
  • Senior Vice President
  • Commercial Strategy & Operations
  • REGENXBIO Inc.
  • Rockville, Maryland
  • Joseph C. Papa
  • Chairman of the Board
  • Chief Executive Officer
  • Bausch Health
  • Bridgewater, New Jersey
  • Kimberly Reed
  • Regeneron Pharmaceuticals
  • Tarrytown, New York
  • Ramiro Ribeiro, MD, PhD
  • Senior Medical Director of Ophthalmology
  • Apellis
  • Cambridge, Massachusetts
  • Carmelo Romano, PhD
  • Executive Director, Ophthalmology
  • Regeneron Pharmaceuticals
  • Tarrytown, New York
  • Charles P. Semba, MD, FACC, FACR
  • Chief Medical Officer
  • Graybug Vision, Inc.
  • Redwood City, California
  • Baldo Scassellati Sforzolini, MBA, MD, PhD
  • Senior Vice President
  • Global Clinical Development and Evidence & Value
  • Allergan
  • Far Hills, New Jersey
  • Sumit Sharma, MD
  • Assistant Professor of Ophthalmology
  • Cleveland Clinic
  • Cole Eye Institute
  • Boston, Massachusetts
  • Riad Sherif, MD
  • CEO
  • Oculis S.A.
  • Lausanne Switzerland
  • Andrew Stewart
  • Associate VP
  • US Commercial Eye Care
  • Allergan
  • Irvine, California
  • Scott C. Upton
  • Managing Director
  • ICG Capital Securities, LLC
  • Charlotte, North Carolina
  • Keith Westby, MBA
  • Senior Vice President and Chief Operating Officer
  • Ophthotech
  • New York, New York
  • Daniel White
  • President & CEO
  • Clearside Biomedical Inc.
  • Alpharetta, Georgia